Boots partners with P&G in Italy
This article was originally published in The Rose Sheet
Executive Summary
As part of its European expansion initiative, U.K.-based beauty and pharmacy group Alliance Boots has partnered with Procter & Gamble in Italy. Boots will "leverage P&G's sales force capacity to distribute and promote" its Boots Laboratories skin-care range to pharmacies in the country, firm says. The line - boasting "clinically proven anti-aging benefits" - launched in France and Portugal in the last two years. Boots plans to launch the range in Italy and Spain in the coming months. "Our objective is to expand Boots Laboratories, and we are delighted to be working in partnership with P&G to make these award-winning products accessible to Italian consumers," Ornella Barra, chief executive of Boots' pharmaceutical wholesale division, says in a release
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.